Accordingly, a significant difference in Survivin expression levels was detected between thin and thick primary cutaneous melanomas (p<0.0001, χ2), whereas thick primary tumors and lymph node metastases did not show statistically significant differential expression. The gene discussed is BIRC5; the disease is cutaneous melanoma.